Colossal Biosciences Acquires Pet Cloning Company to Advance De-Extinction Efforts Colossal’s purchase of ViaGen, known for cloning pets of celebrities, bolsters the biotech firm’s tools for de-extinction and conservation. By Alexandra Tremayne-Pengelly
The $10B Startup Behind the Revived Dire Wolf Reports Another Breakthrough The $10 billion Texas startup says a breakthrough in pigeon germ cells brings the dodo closer to revival. By Alexandra Tremayne-Pengelly
A $10B Gene-Editing Startup Has (Sort of) Brought Back the Extinct Dire Wolf Colossal has managed to breed after genetically engineering ancient dire wolf DNA into genomes of grey wolves, their closest living relatives. By Alexandra Tremayne-Pengelly
Colossal Biosciences CEO Dissects the $10B Startup’s Effort to Bring Back Extinct Animals: Interview By Alexandra Tremayne-Pengelly